Oncoscope Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

Oncoscope General Information

Description

Developer of clinical optical imaging applications. The company develops optical imaging systems which provides images and information on tissue microstructure for the purpose of epithelial tissues in the oral cavity, esophagous, stomach, colon, lung, cervix and bladder.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 318 Blackwell Street
  • Suite 240
  • Durham, NC 27701
  • United States
+1 (919)
Primary Industry
Other Devices and Supplies
Corporate Office
  • 318 Blackwell Street
  • Suite 240
  • Durham, NC 27701
  • United States
+1 (919)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oncoscope Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 23-Feb-2016 Completed Generating Revenue
6. Later Stage VC 21-Jan-2014 Completed Generating Revenue
5. Debt - General 11-Oct-2012 Completed Generating Revenue
4. Later Stage VC (Series A2) 23-Sep-2011 Completed Startup
3. Early Stage VC (Series A1) 26-May-2010 Completed Startup
2. Early Stage VC (Series A) 15-Dec-2008 $2.09M $2.09M Completed Startup
1. Grant 01-Mar-2007 $40K Completed Startup
To view Oncoscope’s complete valuation and funding history, request access »

Oncoscope Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2
Series A1
Series A 2,608,259 $0.001000 $0.8 $0.8 1x $0.8 9.23%
To view Oncoscope’s complete cap table history, request access »

Oncoscope Patents

Oncoscope Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20140275765-A1 Probe assembly and disposable cover particularly for use in endoscope applications of low coherence interferometry Inactive 15-Mar-2013
AU-2009204187-A1 Systems and methods for tissue examination, diagnostic, treatment, and/or monitoring Active 08-Jan-2008
CA-2711643-A1 Systems and methods for tissue examination, diagnostic, treatment, and/or monitoring Inactive 08-Jan-2008
AU-2009204187-B2 Systems and methods for tissue examination, diagnostic, treatment, and/or monitoring Inactive 08-Jan-2008
US-20090177094-A1 Systems and methods for tissue examination, diagnostic, treatment, and/or monitoring Inactive 08-Jan-2008 A61B5/6852
To view Oncoscope’s complete patent history, request access »

Oncoscope Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oncoscope Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Applied Ventures Corporate Venture Capital Minority
Arcus Ventures Venture Capital Minority
Fulcrum Financial Partners Family Office Minority
IDEA Fund Partners Venture Capital Minority
NC Idea Accelerator/Incubator
You’re viewing 5 of 6 investors. Get the full list »

Oncoscope FAQs

  • When was Oncoscope founded?

    Oncoscope was founded in 2006.

  • Where is Oncoscope headquartered?

    Oncoscope is headquartered in Durham, NC.

  • What is the size of Oncoscope?

    Oncoscope has 7 total employees.

  • What industry is Oncoscope in?

    Oncoscope’s primary industry is Other Devices and Supplies.

  • Is Oncoscope a private or public company?

    Oncoscope is a Private company.

  • What is Oncoscope’s current revenue?

    The current revenue for Oncoscope is .

  • How much funding has Oncoscope raised over time?

    Oncoscope has raised $5.73M.

  • Who are Oncoscope’s investors?

    Applied Ventures, Arcus Ventures, Fulcrum Financial Partners, IDEA Fund Partners, and NC Idea are 5 of 6 investors who have invested in Oncoscope.

  • When was Oncoscope acquired?

    Oncoscope was acquired on 23-Feb-2016.

  • Who acquired Oncoscope?

    Oncoscope was acquired by SpectraScience (US).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »